Table 1.
Stimuli used for CT experiments
| Rinse | M | Salt stimuli | M |
| R | 0.01 KCl | N | 0.01 KCl + 0.1 NaCl |
| R | 0.01 KCl | N + Bz | 0.01 KCl + 0.1 NaCl + 5 × 10−6 Bz |
| R | 0.01 KCl | N + Bz + MRPs | 0.01 KCl + 0.1 NaCl + 5 × 10−6 Bz + MRPs (0–1%) |
| R | 0.01 KCl | N + Bz + MRPs + TRPV1t modulatorsa | 0.01 KCl + 0.1 NaCl + 5 × 10−6 Bz + MRPs (0–1%) + TRPV1t modulatorsa |
| R | 0.01 KCl | MSG + Bz + SB | 0.01 KCl + 0.1 MSG + 5 × 10−6 Bz + 1 × 10−6 Bz SB |
| R | 0.01 KCl | MSG + Bz + SB + IMP | 0.01 KCl + 0.1 MSG + 5 × 10−6 Bz + 1 × 10−6 Bz SB + 1 × 10−3 IMP |
| (R)pHb | 0.01 KCl + 0.01 HEPES/Tris | (N + Bz + MRPs)pHb | 0.01 KCl + 0.01 HEPES/Tris + 0.1 NaCl + 5 × 10−6 Bz + MRPs (0–1%) |
| R | 0.01 KCl | Control solution 1 | 0.3 NH4Cl |
| R | 0.01 KCl | Control solution 2 | 0.3 NaCl |
MRPs: GalA-MRP; GlcNH2-MRP; Xyl-MRP; Fru-MRP; Glc-MRP. The concentration of MRPs is in percent. In some experiments, we also tested the effect of the unreacted soy protein fraction.
TRPV1 modulators: RTX (0.25 × 10−6 M); CAP (20 × 10−6 M); ethanol (20% or 40%); SB (N-(3-methoxyphenyl)-4-chlorocinnamide; SB-366791), a specific blocker of TRPV1t. In some experiments, SB was used at 5 × 10−6 M; Bz, a specific blocker of the epithelial Na+ channel.
HEPES (4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid) or Tris (tris(hydroxymethyl)aminomethane) were used to buffer the pH of (R)pH and (N + Bz + MRPs)pH between pH 4.1 and 9.1.